Revisiting Paclitaxel: Where Does the Evidence Stand Today?

Join Drs Eric Secemsky, Marianne Brodmann, and Keith Sterling as they review the evolution of the paclitaxel discussion, examine contemporary evidence from clinical trials and real-world studies, and discuss why both safety and efficacy must remain central to treatment decisions for patients with peripheral arterial disease.

© 2026 HMP Global. All Rights Reserved.

Any views and opinions expressed are those of the author(s) and/or participants and do not necessarily reflect the views, policy, or position of Vascular Disease Management or HMP Global, their employees, and affiliates.